Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: 23rd Congress of the International Association for Breast Cancer Research

Meeting abstract

Transcriptional regulation of apoptosis in mouse mammary gland

MP Boland1, EA Kritikou1, RS Chapman2, JL Heeley1, RWE Clarkson1 and CJ Watson1

1Department of Pathology, University of Cambridge, Cambridge, UK

2CRC Institute for Cancer Studies, University of Birmingham, Birmingham, UK

from 23rd Congress of the International Association for Breast Cancer Research
Düsseldorf, Germany. 13–16 June 2001

Breast Cancer Res 2001, 3(Suppl 1):A12doi:10.1186/bcr336

Received: 10 May 2001
Published: 29 May 2001

© 2001 BioMed Central Ltd

Meeting abstract

Postlactational regression of the mammary gland is characterized by extensive apoptosis of the epithelial compartment. Involution occurs in two phases: an early reversible phase and a later phase accompanied by breakdown of the extracellular matrix and remodeling of the gland. We have used both knockout mice and a cell-culture model to identify the transcription factors that regulate the early phase of involution. Conditional deletion of Stat3 results in diminished apoptosis and delayed involution, whereas, in contrast, loss of IRF-1, a downstream target of Stat1, accelerates the first phase of involution. We have begun to analyze in more detail the molecular events associated with the activation of these transcription factors. Downstream targets have not been identified, although IGFBP-5 may be an indirect target of both Stat3 and IRF-1. In the absence of Stat3, elevated levels of p21, p53 and Stat1 are observed. Using a mammary epithelial cell culture model, KIM-2, and inducible activation of Stat3 and Stat5, we have shown that dimerization of Stat3 alone is sufficient to induce apoptosis of KIM-2 cells. Furthermore, apoptosis can be significantly increased by blocking a survival pathway. In contrast, dimerization of Stat5 provides a differentiation signal and, subsequently, a survival signal for differentiated KIM-2 cells. Interplay between Stat3 and Stat5, identification of downstream targets, and crosstalk with other pathways is now being investigated.

Have something to say? Post a comment on this article!


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions